Free Trial

Brainstorm Cell Therapeutics (BCLI) SEC Filings & 10K Form

Brainstorm Cell Therapeutics logo
$1.16 -0.03 (-2.12%)
As of 10:17 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Brainstorm Cell Therapeutics SEC Filings

DateFilerForm TypeView
05/16/2025
6:15 AM
Brainstorm Cell Therapeutics (Filer)
Form ARS
05/16/2025
6:00 AM
Brainstorm Cell Therapeutics (Filer)
Form DEF 14A
05/16/2025
6:05 AM
Brainstorm Cell Therapeutics (Filer)
Form DEFA14A
05/15/2025
2:07 PM
ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
Form SCHEDULE 13G
05/06/2025
3:30 PM
Brainstorm Cell Therapeutics (Filer)
Form PRE 14A
03/31/2025
6:30 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/31/2025
6:10 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2025
5:30 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/27/2025
7:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
4:25 PM
ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
Form SCHEDULE 13G/A
01/21/2025
4:25 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2025
3:22 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
3:10 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 3/A
01/07/2025
3:11 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:30 PM
ARBEL IRIT (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:31 PM
Bairu Menghisteab (Reporting)
Brainstorm Cell Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:31 PM
Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:32 PM
Brainstorm Cell Therapeutics (Issuer)
Lindborg Stacy (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:32 PM
Brainstorm Cell Therapeutics (Issuer)
Naor Nir (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:33 PM
Brainstorm Cell Therapeutics (Issuer)
Patlis Alla (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:34 PM
Brainstorm Cell Therapeutics (Issuer)
Yablonka Uri (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:34 PM
Brainstorm Cell Therapeutics (Issuer)
Polverino Anthony J. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:36 PM
Brainstorm Cell Therapeutics (Issuer)
FRENKEL JACOB A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/03/2025
4:36 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/14/2024
2:24 PM
ARMISTICE CAPITAL, LLC (Filed by)
Brainstorm Cell Therapeutics (Subject)
Form SC 13G
11/13/2024
6:55 AM
Brainstorm Cell Therapeutics (Subject)
Ruck Matthew J (Filed by)
Form SC 13G
10/30/2024
7:41 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2024
7:00 AM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/01/2024
7:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/29/2024
11:15 PM
Brainstorm Cell Therapeutics (Filer)
Form EFFECT
09/26/2024
3:30 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
3:30 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3/A
09/17/2024
2:32 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
09/16/2024
3:36 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/08/2024
11:15 PM
Brainstorm Cell Therapeutics (Filer)
Form EFFECT
08/28/2024
4:01 PM
Brainstorm Cell Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
08/16/2024
6:00 AM
Brainstorm Cell Therapeutics (Filer)
Form DEF 14A
08/16/2024
6:03 AM
Brainstorm Cell Therapeutics (Filer)
Form ARS
08/14/2024
7:01 AM
Brainstorm Cell Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/14/2024
6:15 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/31/2024
3:08 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
Gold is soaring. Here’s how to get paid from it (Ad)

Gold just broke through $3,300… And while the headlines shout about price targets, something even more powerful is happening behind the scenes… Some investors are using a little-known ETF to collect up to $1,152/month from gold's surge. No trading gold futures. No mining stocks. No vaults. Just a simple fund delivering monthly payouts — like clockwork.

Click here to discover the income ETF behind it all.
07/31/2024
3:09 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:05 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:06 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:06 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:07 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/31/2024
3:07 PM
Brainstorm Cell Therapeutics (Issuer)
Lebovits Chaim (Reporting)
Form 4/A
07/24/2024
3:05 PM
Brainstorm Cell Therapeutics (Issuer)
Dagher Ibrahim B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/19/2024
3:05 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/28/2024
9:49 AM
Brainstorm Cell Therapeutics (Filer)
Form 424B5
06/28/2024
6:30 AM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2024
8:00 AM
Brainstorm Cell Therapeutics (Filer)
Form 424B5
06/26/2024
3:01 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/25/2024
8:03 PM
Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2024
8:04 PM
Brainstorm Cell Therapeutics (Issuer)
HARTOUNIAN HARTOUN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/20/2024
4:24 PM
Brainstorm Cell Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:BCLI) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners